{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "Firstpost"}, "author": "Vibhuti Sanchala, Isha Mehrotra", "title": "How pharma rivals Bharat Biotech, SII have joined forces to fight polio globally - Firstpost", "description": "Bharat Biotech has collaborated with the Netherlands-based Bilthoven Biologicals B.V, a wholly-owned subsidiary of Serum Institute of India, to strengthen production and ensure supply of oral polio vaccines. This news comes three years after a the two pharma \u2026", "url": "https://www.firstpost.com/explainers/pharma-rivals-bharat-biotech-sii-polio-vaccine-13755642.html", "urlToImage": "https://images.firstpost.com/uploads/2024/04/2020-11-29T132442Z_924831709_RC20DK9O45O9_RTRMADP_3_YEMEN-SECURITY-POLIO-1-2024-04-5e567f8f1b13f8a21c758817f2f69510.jpg?im=FitAndFill=(1200,675)", "publishedAt": "2024-04-03T13:30:27Z", "content": "Top vaccine makers and rivals\u00a0Bharat Biotech and Serum Institute of India (SII), putting aside disagreements, have teamed up to eradicate polio globally.\r\nThis news comes three years after a heated p\u2026 [+7184 chars]"}]}